Search Results - P. Rodriguez Otero

Refine Results
  1. 1

    P973: REAL-WORLD STUDY ON ADOPTION OF STANDARD OF CARE (SOC) FOR FRONTLINE TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA (FLTEMM) PATIENTS BETWEEN 2017 AND 2020/2021 ACROSS FRANCE, GERMANY,... by K. Weisel, A. Wadlund, G. Gungor, E. Dergarabetian, C. Pacheco, N. Masurkar, P. Rodriguez-Otero

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  2. 2

    Expansion of CD8+CD57+ T Cells in an Immunocompetent Patient with Acute Toxoplasmosis by R. García-Muñoz, P. Rodríguez-Otero, A. Galar, J. Merino, J. J. Beunza, J. A. Páramo, R. Lecumberri

    Published in Advances in Hematology (2009-01-01)
    Get full text
    Article


  3. 3

    P21: SUBSEQUENT ANTI-MYELOMA THERAPY AFTER IDECABTAGENE VICLEUCEL (IDE-CEL, BB2121) TREATMENT IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM THE KARMMA STUDY by P Rodríguez-Otero, J San-Miguel, LD Anderson, Jr, S Lonial, A Truppel-Hartmann, J Sanford, E Rowe, TB Campbell, N Munshi

    Published in HemaSphere (2022-04-01)
    Get full text
    Article


  4. 4

    P19: BASELINE CORRELATES OF COMPLETE RESPONSE TO IDECABTAGENE VICLEUCEL (IDE-CEL, BB2121), A BCMA-DIRECTED CAR T CELL THERAPY IN PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYEL... by P Rodríguez-Otero, N Shah, N Munshi, J Berdeja, S Jagannath, O Finney, N Martin, A Agarwal, E Rowe, T Campbell, J San-Miguel

    Published in HemaSphere (2022-04-01)
    Get full text
    Article


  5. 5

    21277. REGRESIÓN RÁPIDA DE COMPRESIÓN MIELORRADICULAR CON TERAPIA CAR-T EN PACIENTE CON MIELOMA MÚLTIPLE by C. Pérez Prol, R. Villino Rodríguez, F. Abedrabbo Lombeyda, C. Espinoza Vinces, E. Tamariz Amador, A. Alfonso Piérola, P. Rodríguez Otero, J. Gállego Pérez de Larraya

    Published in Neurology Perspectives (2024-11-01)
    Get full text
    Article


  6. 6

    21271. COMPLICACIONES NEUROLÓGICAS MÁS ALLÁ DE ICANS EN PACIENTES CON MIELOMA MÚLTIPLE TRATADOS CON TERAPIA CÉLULAS T EFECTORAS by C. Pérez Prol, R. Villino Rodríguez, F. Abedrabbo Lombeyda, C. Espinoza Vinces, A. Atorrasagasti Villar, M. Gimeno Rodríguez, E. Tamariz Amador, A. Alfonso Piérola, P. Rodríguez Otero, J. Gállego Pérez de Larraya

    Published in Neurology Perspectives (2024-11-01)
    Get full text
    Article


  7. 7

    21275. SÍNDROME DE NEUROTOXICIDAD ASOCIADO A CÉLULAS INMUNOEFECTORAS EN PACIENTES CON MIELOMA MÚLTIPLE: REVISIÓN DE UNA SERIE MONOCÉNTRICA by C. Pérez Prol, R. Villino Rodríguez, F. Abedrabbo Lombeyda, C. Espinoza Vinces, A. Atorrasagasti Villar, M. Gimeno Rodríguez, E. Tamaríz Amador, A. Alfonso Piérola, P. Rodríguez Otero, J. Gállego Pérez de Larraya

    Published in Neurology Perspectives (2024-11-01)
    Get full text
    Article


  8. 8

    P1463: PHASE I DOSE ESCALATION OF LAVA-051, A NOVEL BISPECIFIC GAMMA-DELTA T-CELL ENGAGER (GAMMABODY™), IN RELAPSED/REFRACTORY HEMATOLOGICAL MALIGNANCIES by A. Broijl, N. van de Donk, F. Bosch, M. V. Mateos, P. Rodriguez-Otero, A. Tucci, P. Ghia, A. Adang, P. Parren, I. Tuinhof, S. Umarale, B. Winograd, H. van der Vliet, A. Kater

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  9. 9

    C003 | MODELING LONG-TERM PROGRESSION-FREE SURVIVAL IN TRANSPLANT-ELIGIBLE AND TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH DARATUMUMAB, BORTEZOMIB, LENALIDO... by F. Gay, P. Sonneveld, S. Zweegman, T. Facon, V. Hungria, N. J. Bahlis, P. Moreau, H. Einsele, M. Boccadoro, F. Borgsten, A. Lam, M. Nobrega, V. Kovacs, J. Wang, M. Rowe, A. Sitthi-Amorn, R. Carson, M.A. Dimopoulos, P. Rodríguez-Otero, S.Z. Usmani

    Published in Haematologica (2025-09-01)
    Get full text
    Article


  10. 10

    S182: TALQUETAMAB, A G PROTEIN-COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D X CD3 BISPECIFIC ANTIBODY, IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED EFFICACY AND SAFETY RESULTS FR... by M. C. Minnema, A. Krishnan, J. G. Berdeja, A. Oriol, N. W. van de Donk, P. Rodríguez-Otero, D. Morillo, M.-V. Mateos, L. J. Costa, J. Caers, D. Vishwamitra, J. Ma, S. Yang, B. W. Hilder, J. Tolbert, J. D. Goldberg, A. Chari

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  11. 11

    P10: TALQUETAMAB, A G PROTEIN-COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED PHASE 1 RE... by N. W. C. J van de Donk, M C Minnema, J G Berdeja, A Oriol, A Krishnan, P Rodríguez-Otero, E Askari, M Mateos, L. J Costa, R Verona, J Ma, S Girgis, S Yang, B. W Hilder, J Russell, J. D Goldberg, A Chari

    Published in HemaSphere (2022-04-01)
    Get full text
    Article


  12. 12

    C002 | SUBCUTANEOUS DARATUMUMAB + BORTEZOMIB/LENALIDOMIDE/DEXAMETHASONE WITH DARA + LENALIDOMIDE MAINTENANCE IN TRANSPLANT-ELIGIBLE PATIENTS WITH NDMM: ANALYSIS OF SUSTAINED MINIMA... by E. Antonioli, P. Moreau, P. Sonneveld, H. Einsele, H. Quach, P. Joy Ho, M. Beksac, C. Hulin, X. Leleu, S. Mangiacavalli, A. Perrot, M. Cavo, A. Belotti, A. Broijl, H. Pei, A. Sitthi-Amorn, R. L. Carson, P. Rodríguez-Otero, M.A. Dimopoulos, M. Boccadoro

    Published in Haematologica (2025-09-01)
    Get full text
    Article


  13. 13

    P898: COMPARISON OF TECLISTAMAB WITH BELANTAMAB MAFODOTIN IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA USING MATCHING-ADJUSTED INDIRECT TREATMENT COMP... by M. Delforge, S. Z. Usmani, N. W. van de Donk, A. L. Garfall, P. Moreau, A. Oriol, A. K. Nooka, L. Rosinol, N. Bahlis, P. Rodriguez-Otero, T. Martin, J. Diels, S. Van Sanden, L. Pei, E. Ammann, R. Kobos, M. Slavcev, J. Smit, A. Londhe, A. Krishnan

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  14. 14

    S188: TECLISTAMAB IN COMBINATION WITH DARATUMUMAB, A NOVEL, IMMUNOTHERAPY-BASED APPROACH FOR THE TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED PHASE 1B RESULTS by P. Rodriguez Otero, A. D’Souza, D. Reece, N. W. van de Donk, A. Chari, A. Krishnan, T. Martin, M. V. Mateos, D. Morillo, D. Hurd, L. Rosinol, A. S. Balari, R. Wäsch, D. Vishwamitra, S. X. Wang Lin, T. Prior, L. Vandenberk, M.-A. D. Smit, A. Oriol, B. Dholaria

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  15. 15

    PB2014: TECLISTAMAB VS SELINEXOR-DEXAMETHASONE IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA: A MATCHING-ADJUSTED INDIRECT COMPARISON by L. Rosinol, S. Z. Usmani, N. Bahlis, A. Y. Krishnan, A. K. Nooka, A. Oriol, M. Delforge, A. L. Garfall, N. W. van de Donk, P. Rodríguez Otero, T. G. Martin, J. Diels, S. Van Sanden, L. Pei, E. Ammann, R. Kobos, M. Slavcev, J. Smit, A. Londhe, P. Moreau

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  16. 16

    B08 IDECABTAGENE VICLEUCEL VERSUS STANDARD REGIMENS IN PATIENTS WITH TRIPLE-CLASS–EXPOSED RELAPSED AND REFRACTORY MULTIPLE MYELOMA: KARMMA-3 A PHASE 3 RANDOMIZED CONTROLLED TRIAL... by P. Rodríguez-Otero, S. Ailawadhi, B. Arnulf, K. Patel, M. Cavo, A.K. Nooka, S. Manier, N. Callander, L.J. Costa, R. Vij, N.J. Bahlis, P. Moreau, S.R. Solomon, M. Delforge, J. Berdeja, A. Truppel-Hartmann, Z. Yang, L. Favre-Kontula, F. Wu, J. Piasecki, M. Cook, S. Giralt

    Published in HemaSphere (2023-05-01)
    Get full text
    Article


  17. 17

    P13: CAN PATIENT-REPORTED OCULAR SYMPTOMS GUIDE DOSE MODIFICATIONS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING BELANTAMAB MAFODOTIN? by R Popat, A Badros, S Kumar, P Rodriguez-Otero, A Cohen, S Manier, P Voorhees, F Gay, R Rifkin, T Martin, A Chari, K Weisel, A Farooq, B Jeng, W Chng, H Lee, J Berdeja, V Jadhav, A Tosolini, L Eliason, A Palumbo, M Dimopoulos, S Lonial, S Trudel, P Richardson, E Terpos

    Published in HemaSphere (2022-04-01)
    Get full text
    Article


  18. 18

    B04: COMBINATION OF SUBCUTANEOUS TECLISTAMAB WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM A PHASE 1B MULTICOHORT STUDY by P Rodriguez-Otero, B Dholaria, E Askari, D Reece, N van de Donk, A Chari, H Goldschmidt, A Krishnan, T Martin, M Mateos, D Morillo, C Rodriguez, L Rosinol, J San-Miguel, A Balari, R Wäsch, K Weisel, R Verona, S Lin, T Prior, M Wade, B Weiss, J Goldberg, A Oriol, P Hari

    Published in HemaSphere (2022-04-01)
    Get full text
    Article


  19. 19

    B06: SUBCUTANEOUS TALQUETAMAB IN COMBINATION WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): PHASE 1B RESULTS by M Mateos, P Hari, N Bahlis, A Chari, NWCJ van de Donk, B Dholaria, AL Garfall, H Goldschmidt, KM Kortüm, A Krishnan, T Martin, D Morillo, A Oriol, D Reece, C Rodriguez, P Rodríguez-Otero, JF San-Miguel, SZ Usmani, R Verona, SXW Lin, TJ Prior, M Wade, B Weiss, JD Goldberg, E Askari

    Published in HemaSphere (2022-04-01)
    Get full text
    Article


  20. 20

    P28 EFFICACY AND SAFETY OF CILTACABTAGENE AUTOLEUCEL (CILTA-CEL) IN PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA (MM) AFTER EXPOSURE TO NON-CELLULAR ANTI-B-CELL MATURATION ANTIGEN (B... by N. van de Donk, M.-V. Mateos, Y.C. Cohen, P. Rodriguez-Otero, B. Paiva, A.D. Cohen, T. Martin, A. Suvannasankha, D. Madduri, C. Corsale, J.M. Schecter, K.C. De Braganca, C.C. Jackson, H. Varsos, W. Deraedt, T. Roccia, P. Mistry, X. Xu, K. Li, E. Zudaire, M. Akram, L. Pacaud, I. Avivi, J. San-Miguel

    Published in HemaSphere (2023-05-01)
    Get full text
    Article


Search Tools: